Velaz, LalyChen, Yi-DerChalovich, Joseph2011-01-272011-05-172011-01-272011-05-171993-08Biophysical Journal; 65:2 p. 892-898http://hdl.handle.net/10342/3106The protein caldesmon inhibits actin-activated ATP hydrolysis of myosin and inhibits the binding of myosin*ATP to actin. Afragment isolated from a chymotryptic digest of caldesmon contains features of the intact molecule that make it useful as a selective inhibitor of the binding of myosin ATP complexes to actin without having the complexity of binding to myosin. The COOH-terminal 20 kDa region of caldesmon binds to actin with one-sixth the affinity of caldesmon with a stoichiometry of binding of one fragment per two actin monomers. This contrasts with the 1:6-9 stoichiometry of intact caldesmon. The binding of the 20 kDa fragments to actin is totally reversed by Ca2+-calmodulin and, like intact caldesmon, the 20 kDa fragments are competitive with the binding of myosin subfragments to actin. This competition with myosin binding is largely responsible for the inhibition of ATP hydrolysis, although both the fragments and intact caldesmon also reverse the potentiation of ATPase activity caused by tropomyosin. These polypeptides are useful both in defining the function of caldesmon and in studying the role of weakly bound cross-bridges in muscle. Originally published Biophysical Journal, Vol. 65, No. 2, Aug 1993en-USAuthor notified of opt-out rights by Cammie Jennings prior to upload of this article.CaldesmonATP hydrolysisMyosin bindingArticlePMC122578910.1016/S0006-3495(93)81113-5